Company intelligence / Profile preview

Cormeum Lab Services

Saint Rose, Louisiana, United States

Ownership: Private
Employees: ~24
Development stage: Other

Overview

Cormeum Lab Services operates as a high-throughput diagnostic laboratory providing advanced molecular diagnostics for infectious diseases, including FDA Emergency Use Authorization for COVID-19 RT-PCR testing, with a focus on rapid turnaround and comprehensive in-house testing across multiple sample types. Their COVID-19 test demonstrated 100% specificity and sensitivity in the FDA EUA process based on review of ~175 clinical samples.[7][1]

Therapeutic areas: HematologyInfectious DiseasesOther
Modalities: Diagnostic testRT-PCR-based diagnosticsMolecular diagnostics
Industry: Molecular Diagnostics

Partnerships

Integration with telehealth services via Sensiva Health[7]Partnerships with large health systems, long-term care facilities, and public health initiatives[1]

Beyond the preview

Go deeper on Cormeum Lab Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cormeum Lab Services.

Explore the full profile